Clinical Trial Update: Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476 [Phase 2]

View source ↗

Summary

A Phase II dose-ranging study evaluating SPD476 in subjects with mild to moderate ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SPD476

Snippet

Sponsor: Shire | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED